ACAD
ACADIA Pharmaceuticals (ACAD) Investor Questions
Review ACADIA Pharmaceuticals (ACAD) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- ACADIA Pharmaceuticals
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 79
- Annual revenue
- $1.07B
- Annual net income
- $391.00M
- Annual free cash flow
- $105.15M
ACADIA Pharmaceuticals (ACAD) Investor Questions research
ACADIA Pharmaceuticals trades under the ticker ACAD. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review ACAD through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.